MSU Drug Discovery
**Next Round of MDG -
Check back for RFA
"Marley's marvelous success"
"The novel rexinoid MSU-42011 is effective for the treatment of preclinical Kras-driven lung cancer" Moerland et al., Scientific Reports, December 2020
"Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer's disease and cognitive functions" Liu et al., Scientific Reports, October 2020
- "Inhibiting Mycobacterium tuberculosis DosRST signaling by targeting response regulator DNA binding and sensor kinase heme" Zheng et al., ACS Chem. Biol. March 2020
Other Resources Available: